Peterson & Associates, P.C.

Our Blog

Breaking News: Medtronic Infuse Bone Graft Off-Label Promotion

Categorized as Defective Medical Devices

Medtronic Infuse Bone Graft Lawsuit Information In 2002, the FDA granted Medtronic approval for its Infuse Bone Graft, a man made bone growth product for limited use in the lumbar spine region. Despite this limited scope of approval, Medtronic, Inc., allegedly, promoted off-label uses of the Infuse bone graft including surgeries in the cervical spine, the thoracic spine, and also lateral and posterior approach of the lumbar spine.

According to a recent NY Times article:

“Reports that doctors conducting medical trials while on Medtronic’s payroll may have hidden serious side effects for patients are deeply troubling,” Senator Baucus said in a statement. “We need to do everything we can to ensure companies aren’t concealing serious medical complications from patients just to increase profits,” he added.

Such off-label uses of the Medtronic Infuse Bone Graft have been associated with the following injuries:

  • Severe swelling of your neck or throat
  • Excess bone growth in the spine
  • Chronic and severe pain in your legs or arms (inflammatory reaction)
  • Male infertility
  • Pancreatic, prostate or breast cancer
  • Nerve damage
  • Death

Peterson & Associates, P.C. fights hard to make sure medical device companies take responsibility for the pain and suffering they cause. Get immediate legal assistance by calling us.